Task: Answer the multiple-choice question.
Query: Which drug exhibits a 20.684% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CCOc1ccc(NC(=O)CCCCn2c(=O)[nH]c3ccsc3c2=O)cc1
b) CC(C)N1CCN(c2ccncc2S(=O)(=O)N2CCOCC2)CC1
c) CCn1cc(CN(C)S(=O)(=O)c2ccc3ccccc3c2)c(C)n1
d) COC(=O)C(CCSC)NC(=O)c1cc2c(n(-c3ccccc3)c1=O)CC(C)(C)CC2=O
e) CCN(CC)CCN=Cc1c(O)n(CCC2=CCCCC2)c(=O)[nH]c1=O
Answer: b. CC(C)N1CCN(c2ccncc2S(=O)(=O)N2CCOCC2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N1CCN(c2ccncc2S(=O)(=O)N2CCOCC2)CC1
CC(C)N1CCN(c2ccncc2S(=O)(=O)N2CCOCC2)CC1
4-[4-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]sulfonylmorpholine